Login / Signup

The pharmacological management of asthma in adults: 2023 update.

Maria Gabriella MateraBarbara RinaldiRosa AnnibaleVito De NovellisMario Cazzola
Published in: Expert opinion on pharmacotherapy (2024)
severe asthma. However, there is still room for improvement, such as the discovery of new molecules that specifically target chronic inflammation and, most importantly, the ability to provide solutions to the various areas of uncertainty that still exist. Also finding solutions to improve the accessibility and affordability of rescue ICS in resource-constrained settings is critical.
Keyphrases
  • chronic obstructive pulmonary disease
  • oxidative stress
  • small molecule
  • lung function
  • high throughput
  • allergic rhinitis
  • cystic fibrosis